Abstract
Chemotherapy has resulted in a better quality of life and increased survival of oncology patients. However, there is a greater risk of cardiovascular disease due to exposure to potentially cardiotoxic drugs such as anthracyclines. It is suspected that patients in remission of hematological disease and over a year without anthracyclines may present signs of cardiotoxicity, even in the abse…